Kalvista Pharmaceuticals (KALV) Q1 2025 Earnings

Mar 12Confirmed
Q3 2024
Q3 2024
Q4 2024
Q1 2025
-1.02
-0.92
-0.82
-0.71

Details

Expected EPS
-0.866
Actual EPS
-0.92
Surprise EPS
-0.05
Surprise Percent
-6.24%

Description

⁨Kalvista Pharmaceuticals⁩ (⁦KALV⁩) has reported earnings of ⁦-0.92⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts